Press release
Heart Failure Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight
Heart Failure Market
Discover which therapies are expected to grab the Heart Failure Market Share @ Heart Failure Market Outlook- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key Takeaways from the Heart Failure Market Research Report
• In May 2025, AstraZeneca announced a study will include an optional pre-screening period to facilitate sites' identification of potentially eligible participants to enter the full screening assessments. Participants will not be required to visit the site and no informed consent is required for the optional pre-screening period. The pre-screening assessments do not replace the full screening tests at Visit 1.
• In May 2025, Boehringer Ingelheim conducted a study is open to adults aged 18 or above legal age with heart failure. People can join the study if they have heart failure symptoms and a left ventricular ejection fraction (LVEF) of 40% or more. The purpose of this study is to find out whether vicadrostat (BI 690517) in combination with empagliflozin helps people with heart failure.
• In May 2025, Bristol-Myers Squibb organized a study is to evaluate the safety, tolerability, and exposure-response (E-R) of BMS-986435/MYK-224 in participants with symptomatic Heart Failure with Preserved Ejection Fraction (HFpEF).
• The increase in Heart Failure Market Size is a direct consequence of the increasing patient population and anticipated launch of emerging therapies in the 7MM.
• As per DelveInsight analysis, the Heart Failure market is anticipated to witness growth at a considerable CAGR.
• The leading Heart Failure Companies working in the market include Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others.
• Promising Heart Failure Pipeline Therapies in the various stages of development include CXL-1020, Strata 1 CXL-1020, Ularitide, JTT-861 Capsules, JARDIANCE®, Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Bisoprolol, Empagliflozin, Lixivaptan, and others.
Stay ahead in the Heart Failure Therapeutics Market with DelveInsight's Strategic Report @ Heart Failure Market Outlook- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Epidemiology Insights
The epidemiology section of Heart Failure offers insights into both historical and current patient populations, as well as forecasted trends across seven major countries. This section aids in understanding the factors behind present and projected trends through analysis of various studies and input from key opinion leaders. Additionally, this portion of the market report provides information on the diagnosed patient pool, trends, and underlying assumptions.
Download the report to understand which factors are driving Heart Failure Epidemiology trends @ Heart Failure Prevalence- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Drugs Market
The Heart Failure Drugs Market is expected to witness substantial growth in the coming years as more targeted therapies receive regulatory approval and enter clinical practice. Additionally, ongoing research efforts aimed at better understanding the molecular mechanisms underlying Heart Failure signaling in Heart Failure are likely to uncover new therapeutic targets and further expand treatment options for patients.
Heart Failure Treatment Market Landscape
The Heart Failure treatment market landscape has witnessed significant advancements over the past years, with targeted therapies playing a crucial role in improving outcomes for patients. Among these targeted therapies, the emergence of Heart Failure has garnered attention in the medical community, presenting both challenges and opportunities in treatment strategies.
To know more about Heart Failure treatment guidelines, visit @ Heart Failure Treatment Market Landscape- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Heart Failure Market Outlook
The report's outlook on the Heart Failure market aids in developing a comprehensive understanding of historical, current, and projected trends. This is achieved by examining the influence of existing Heart Failure therapies, unmet needs, as well as drivers, barriers, and the demand for advanced technology. This section provides detailed insights into the trends of each marketed Heart Failure drug and late-stage pipeline therapy.
Heart Failure Drugs Uptake
The drug chapter of the Heart Failure report provides a comprehensive analysis of both marketed drugs and late-stage pipeline drugs for this condition. It delves into the details of clinical trials, pharmacological actions, agreements, collaborations, approvals, patents, and advantages, and disadvantages of each drug, as well as the latest news and press releases related to Heart Failure.
Major Heart Failure Companies
Several Heart Failure Companies working in the market include Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others
Learn more about the FDA-approved drugs for Heart Failure @ Drugs for Heart Failure Treatment- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Scope of the Heart Failure Market Research Report
• Coverage- 7MM
• Study Period- 2019-2032
• Heart Failure Companies- Roche, Pfizer, Novo Nordisk, Merck & Co, AstraZeneca, GlaxoSmithKline, Bayer, Bristol-Myers Squibb, Eli Lilly and Company, Novartis, Sanofi, Johnson & Johnson, Takeda Pharmaceutical Company Limited, AbbVie, Gilead Sciences, Amgen, Biogen, Moderna, Regeneron Pharmaceuticals, and Vertex Pharmaceuticals, and many others
• Heart Failure Pipeline Therapies- CXL-1020, Strata 1 CXL-1020, Ularitide, JTT-861 Capsules, JARDIANCE®, Allogeneic Mesenchymal Bone Marrow Cells (aMBMC), Bisoprolol, Empagliflozin, Lixivaptan, and others.
• Heart Failure Market Dynamics: Heart Failure Market Drivers and Barriers
• Heart Failure Market Access and Reimbursement, Unmet Needs, KOL's Views, and Analyst's Views
Discover more about Heart Failure Drugs in development @ Heart Failure Clinical Trials Assessment- https://www.delveinsight.com/sample-request/heart-failure-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Table of Content
1. Key Insights
2. Executive Summary of Heart Failure
3. Competitive Intelligence Analysis for Heart Failure
4. Heart Failure: Market Overview at a Glance
5. Heart Failure: Disease Background and Overview
6. Patient Journey
7. Heart Failure Epidemiology and Patient Population
8. Treatment Algorithm, Current Treatment, and Medical Practices
9. Heart Failure Unmet Needs
10. Key Endpoints of Heart Failure Treatment
11. Heart Failure Marketed Products
12. Heart Failure Emerging Therapies
13. Heart Failure: Seven Major Market Analysis
14. Attribute analysis
15. 7MM: Market Outlook
16. Access and Reimbursement Overview of Heart Failure
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight Capabilities
22. Disclaimer
List of Top Selling Market Research Reports in 2025
Radiation retinopathy market- https://www.delveinsight.com/sample-request/radiation-retinopathy-market
Immune checkpoints activators market- https://www.delveinsight.com/report-store/immune-checkpoint-inhibitors-market
Cystic fibrosis Market- https://www.delveinsight.com/report-store/cystic-fibrosis-market
Palmoplantar pustulosis market- https://www.delveinsight.com/report-store/palmoplantar-pustulosis-market
Smoking cessation market- https://www.delveinsight.com/report-store/smoking-cessation-and-nicotine-addiction-market
Surgical energy instruments market- https://www.delveinsight.com/report-store/surgical-energy-instruments-electrosurgical-devices-market
Tay-Sachs market- https://www.delveinsight.com/report-store/tay-sachs-disease-market
Attention deficit hyperactivity disorder market- https://www.delveinsight.com/report-store/attention-deficit-hyperactivity-disorder-adhd-market
Medical marijuana market- https://www.delveinsight.com/report-store/medical-marijuana-market
Open angle glaucoma market- https://www.delveinsight.com/report-store/glaucoma-market
Acute myeloid leukemia market- https://www.delveinsight.com/report-store/acute-myeloid-leukemia-aml-market
Asperger syndrome market- https://www.delveinsight.com/report-store/autism-spectrum-disorder-asd-market
Bone growth stimulators market- https://www.delveinsight.com/report-store/bone-growth-stimulators-market
Cardiogenic shock market- https://www.delveinsight.com/report-store/cardiogenic-shock-market
Pacemakers market- https://www.delveinsight.com/report-store/pacemakers-market
Pediatric brain tumor market- https://www.delveinsight.com/report-store/pediatric-brain-tumors-market
Pelizaeus-merzbacher disease market- https://www.delveinsight.com/report-store/pelizaeus-merzbacher-disease-market
Peritoneal carcinomatosis market- https://www.delveinsight.com/report-store/peritoneal-carcinomatosis-pc-market
Pipeline assessment services- https://www.delveinsight.com/consulting/pipeline-assessment-services
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
Company Name: DelveInsight Business Research LLP
Contact Person: Yash Bhardwaj
Email: info@delveinsight.com
Phone: 09650213330
Address: 304 S. Jones Blvd #2432
City: Las Vegas
State: NV
Country: United States
Website: https://www.delveinsight.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Heart Failure Treatment Market Size in 7MM is expected to grow at a decent CAGR by 2032, estimates DelveInsight here
News-ID: 4053211 • Views: …
More Releases from DelveInsight Business Research LLP
Positive Airway Pressure Device Market to Register Incremental Growth at a CAGR …
The Positive Airway Pressure Devices Market was valued at USD 1.92 billion in 2023, growing at a CAGR of 8.40% during the forecast period from 2024 to 2030 to reach USD 3.12 billion by 2030. The increasing prevalence of obstructive sleep apnea and chronic respiratory conditions, such as chronic obstructive pulmonary disease, drives the demand for positive airway pressure devices as they work by delivering a continuous or variable flow…
Medical Device Testing Services Market to Register Incremental Growth at a CAGR …
The Global Medical Device Testing Services Market was valued at USD 9.15 billion in 2023, growing at a CAGR of 4.82% during the forecast period from 2024 to 2030 to reach USD 12.10 billion by 2030. The medical device testing services market is witnessing positive growth owing to various factors such as the growing necessity for validation and verification of medical devices due to strict government regulations.
Key Takeaways from the…
General Surgery Device Market to Register Incremental Growth at a CAGR of ~5.89% …
The Global General Surgery Device Market is estimated to grow at a CAGR of 5.89% during the forecast period from 2024 to 2030. The demand for general surgery devices is primarily being boosted by the growing prevalence of chronic disease such as cardiovascular diseases, oncological disorders, and others. Several chronic diseases may require surgical intervention for the management or treatment thereby boosting the market of general surgery devices.
Key Takeaways from…
Usher Syndrome Treatment Market Size in 7MM is expected to grow at a decent CAGR …
DelveInsight's " Usher Syndrome Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of Usher Syndrome, historical and forecasted epidemiology as well as the Usher Syndrome market trends in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.
Unlock detailed insights into the Usher Syndrome Market by downloading the comprehensive report from DelveInsight @ Usher Syndrome Treatment Market Size- https://www.delveinsight.com/sample-request/usher-syndrome-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=ypr
Key…
More Releases for Heart
Heart disease and Heart Attacks - Kaffailham.gr
Καρδιολόγος Αθηνα - https://kaffailham.gr
When people talk about heart disease or heart attacks. The arteries that they are talking about are the arteries that actually provide blood to the heart. Remember the heart itself is a muscle. It itself needs oxygen. So you have these arteries right over here, the red tubes. Those are arteries. and then the blue ones are veins. They're taking the de-oxygenated blood away from the tissue…
Artificial Heart Implant Market May See a Big Move | Major Giants Jarvik Heart, …
The Latest survey report on Artificial Heart Implant Market sheds lights on changing dynamics of each of the subsegments of Industry. As the shift to value continues, Artificial Heart Implant organizations have the dual challenge of increasing interoperability to improve clinical performance and the patient experience. Some of the companies listed in the study from complete survey list are Medtronic, Boston Scientific, Abbott, Terumo, B.Braun, SynCardia, BiVACOR, CARMAT, ReinHeart TAH…
Heart Pump Device Market - Potential Innovations 2025 | Terumo, Jarvik Heart
Heart Pump Device Market: Snapshot
Heart pump devices are essentially mechanical pumps playing the role of ventricular assist devices. These are surgically implanted and are used for temporarily supporting the functions of heart in people with weak heart or irregular blood flow. These devices are notably used as a bridge to cardiac transplantation for patients suffering with end stage heart failure. They can also be used in patients during and after…
Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure)-Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.
Heart failure is also known as congestive heart failure (CHF). CHF is a condition in which the heart is no longer able to pump out enough oxygen-rich blood. Symptoms include cough, fatigue, weakness, faintness, loss of appetite, swollen (enlarged) liver…
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017 to its growing collection of premium market research reports.
Summary
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2017, provides an overview of the Congestive Heart Failure (Heart Failure) (Cardiovascular) pipeline landscape.
Heart failure is also known as congestive heart failure (CHF).…
Congestive Heart Failure (Heart Failure) Market Research Report
Latest industry research report on: Congestive Heart Failure (Heart Failure) Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
GlobalData's clinical trial report, Congestive Heart Failure (Heart Failure) Global Clinical Trials Review, H1, 2017" provides an overview of Congestive Heart Failure (Heart Failure) clinical trials scenario. This report provides top line data relating to the clinical trials on Congestive Heart Failure (Heart Failure). Report includes an…
